Differences in cytokine levels due to gender in colorectal cancer patients

Cytokine

Volumn 50, Issue 1, 2010, Pages 91-93

  Sharma, A ^a   Greenman, J ^a   Walker, L G ^a   Monson, J R T ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Cytokines; Gender; IL 1 ; IL 6

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; ELECTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LINEAR MODELS; MALE; NEOPLASM STAGING; SEX CHARACTERISTICS;

EID: 77049123175     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.01.002     Document Type: Article

References (33)

1. Coleman M.P., Rachet B., Woods L.M., et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90 (2004) 1367-1373
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
3. Boyle P., and Langman J.S. ABC of colorectal cancer: epidemiology. BMJ 321 (2000) 805-808
4. Link K.H., Sagban T.A., Morschel M., et al. Colon cancer: survival after curative surgery. Langenbecks Arch Surg 390 2 (2004) 83-93
5. O'Connell J.B., Maggard M.A., and Ko C.Y. Colon cancer survival rates with the new American joint committee on cancer sixth edition staging. J Natl Cancer Inst 96 (2004) 1420-1425
6. Wang X., Hershman D.L., Abrams J.A., et al. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br J Cancer 97 12 (2007) 1606-1612
7. Sinha I., Cho B.S., Roelofs K.J., et al. Female gender attenuates cytokine and chemokine expression and leukocyte recruitment in experimental rodent abdominal aortic aneurysms. Ann N Y Acad Sci 1085 (2006) 367-379
8. Zellweger R., Wichmann M.W., Ayala A., et al. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25 (1997) 106-110
9. Sharma R., Zucknick M., London R., et al. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin Colorectal Cancer 7 5 (2008) 331-337
10. Wu S., Boyer C.M., Whitaker R.S., et al. Tumor necrosis factor-alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor-alpha expression. Cancer Res. 53 8 (1993) 1939-1944
11. Smith M.D., Barg E., Weedon H., et al. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Ann Rheum Dis 62 4 (2003) 303-307
12. Himmerich H., Fulda S., and Linseisen J. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17 (2006) 196-201
13. Sperry J.L., Friese R.S., Frankel H.L., et al. Male gender is associated with excessive IL-6 expression following severe injury. J Trauma 64 3 (2008) 572-578
14. Ertan T., Keskek M., Kilic M., et al. Effects of gender difference in early cytokine levels in trauma patients. Bratisl Lek Listy 108 3 (2007) 128-132
15. Imahara S.D., Jelacic S., Junker C.E., and O'Keefe G.E. The influence of gender on human innate immunity. Surgery 138 2 (2005) 275-282
16. Aulock S.V., Deininger S., Draing C., et al. Gender difference in cytokine secretion on immune stimulation with LPS and LTA. J Interferon Cytokine Res 26 12 (2006) 887-892
17. Wichmann M.W., Muller C., Hornung H.M., et al. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg 88 (2001) 1092-1098
18. Bozcuk H., Uslu G., and Samur M. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 27 (2004) 58-65
19. Galizia G., Orditura M., and Romano C. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 102 (2002) 169-178
20. Salgado R., Junius S., and Benoy I. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer 103 (2003) 642-646
21. Zhang G.J., and Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19 (1999) 1427-1432
22. Angele M.K., and Chaudry I.H. Surgical trauma and immunosuppression: pathophysiology and potential immunomodulatory approaches. Langenbecks Arch Surg 390 (2005) 333-341
23. Rossouw J.E., Anderson G.L., and Prentice R.L. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
24. Kurebayashi S., Miyashita Y., Hirose T., et al. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor Steroid. Biochem Mol Biol 60 1-2 (1997) 11-17
25. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 7031 (2005) 400-404
26. Sharma R.A., Dalgleish A.G., Steward W.P., and O'Byrne K.J. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal caner. Oncol Rep 10 5 (2003) 1625-1631
27. Evans C., Morrison I., Heriot A.G., et al. The correlation between colorectal cancer rates of proliferation and apoptosis and systemic cytokine levels; plus their influence upon survival. Br J Cancer 94 10 (2006) 1412-1419
28. Man S.F., Xuekui Z., Vessey R., et al. The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study. Ther Adv Respir Dis 3 2 (2009) 73-80
29. Triggiani M., Granata F., Petraroli A., et al. Inhibition of secretory phospholipase A2-induced cytokine production in human lung macrophages by budesonide. Int Arh Allergy Immunol 150 2 (2009) 144-155
30. Weis F., Beiras-Fernandez A., Schelling G., et al. Stress doses of hydrocortisone in high-risk patients undergoing cardiac surgery: effects on interleukin-6 to interleukin-10 ratio and early outcome. Crit Care Med 37 5 (2009) 1685-1690
31. Heering P., Morgera S., Schmitz F.J., et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23 3 (1997) 288-296
32. Haase M., Bellomo R., Baldwin I., et al. The effect of three different miniaturized blood purification devices on plasma cytokine concentration in an ex vivo model of endotoxinemia. Int J Artif Organs 31 8 (2008) 722-729
33. Haase M., Bellomo R., Morgera S., et al. High cut-off point membranes in septic acute renal failure: a systematic review. Int J Artif Organs 30 12 (2007) 1031-1041